NANNI, CRISTINA
NANNI, CRISTINA
11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma.
2009-01-01 Maleddu A.; Pantaleo M.A.; Castellucci P.; Astorino M.; Nanni C.; Nannini M.; Busato F.; Di Battista M.; Farsad M.; Lodi F.; Boschi S.; Fanti S.; Biasco G.
11C-Choline PET/CT in hormonal resistant patients after radical prostatectomy
2013-01-01 Francesco Ceci, Paolo Castellucci, Riccardo Schiavina, Chiara Fuccio, Stefano Boschi, Daniele Romagnoli, Elena Tabacchi, Marcelo Mamede, Cristina Nanni, Stefano Fanti
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications
2014-01-01 Bonfiglioli, Rachele; Nanni, Cristina; Martignani, Cristian; Zanoni, Lucia; La Donna, Raffaele; Diemberger, Igor; Boriani, Giuseppe; Pettinato, Cinzia; Sambuceti, Gianmario; Fanti, Stefano; Mansi, Luigi
(18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging.
2008-01-01 Lopci E.; Burnelli R.; Ambrosini V.; Nanni C.; Castellucci P.; Biassoni L.; Rubello D.; Fanti S.
18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR.
2012-01-01 Lopci E.; Piccardo A.; Nanni C.; Altrinetti V.; Garaventa A.; Pession A.; Cistaro A.; Chiti A.; Villavecchia G.; Fanti S.
18F-FACBC COMPARED WITH 11C-CHOLINE PET/CT IN PATIENTS WITH BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY: A PROSPECTIVE STUDY IN 79 PATIENTS
2014-01-01 R. Schiavina; C. Pultrone; L. Zanoni; C. Nanni; M. Borghesi; V. Vagnoni; G. Passaretti; L. Bianchi; G. Gentile; C. Del Prete; S. Fanti; G. Martorana; E. Brunocilla
18F-FACBC PET/CT in comparison to 11c-choline for the detection of prostate cancer relapse after radical prostatectomy: A perspective study in 50 patients
2014-01-01 R. Schiavina; E. Brunocilla; C. Nanni; M. Borghesi; F. Ceci; L. Zanoni; V. Vagnoni; L. Della Mora; M. Cevenini; C. Del Prete; S. Fanti; G. Martorana
18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.
2008-01-01 Nanni C; Rubello D; Zamagni E; Castellucci P; Ambrosini V; Montini G; Cavo M; Lodi F; Pettinato C; Grassetto G; Franchi R; Gross MD; Fanti S.
18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin
2006-01-01 Ambrosini V; Nanni C; Rubello D; Moretti A; Battista G; Castellucci P; Farsad M; Rampin L; Fiorentini G; Franchi R; Canini R; Fanti S.
18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse A Comparison to 11C-Choline PET/CT
2015-01-01 Nanni C; Schiavina R; Brunocilla E; Boschi S; Borghesi M; Zanoni L; Pettinato C; Martorana G; Fanti S
(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours.
2010-01-01 Ambrosini V.; Nanni C.; Zompatori M.; Campana D.; Tomassetti P.; Castellucci P.; Allegri V.; Rubello D.; Montini G.; Franchi R.; Fanti S.
68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results.
2010-01-01 Nanni C.; Errani C.; Boriani L.; Fantini L.; Ambrosini V.; Boschi S.; Rubello D.; Pettinato C.; Mercuri M.; Gasbarrini A.; Fanti S.
68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results.
2010-01-01 Ambrosini V.; Zompatori M.; De Luca F.; D'Errico A.; Allegri V.; Nanni C.; Malvi D.; Tonveronachi E.; Fasano L.; Fabbri M.; Fanti S.
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors.
2010-01-01 Ambrosini V.; Campana D.; Bodei L.; Nanni C.; Castellucci P.; Allegri V.; Montini G.C.; Tomassetti P.; Paganelli G.; Fanti S.
A novel model of CCl4-induced cirrosi with ascites in the mouse.
2009-01-01 Domenicali M; Caraceni P; Giannone F; Baldassarre M; Lucchetti G; Quarta C; Patti C; Catani L; Nanni C; Lemoli RM; Bernardi M.
A review discussing fluciclovine (18F) PET/CT imaging in the detection of recurrent prostate cancer
2018-01-01 Zanoni, Lucia; Bossert, Irene; Matti, Antonella; Schiavina, Riccardo; Pultrone, Cristian; Fanti, Stefano; Nanni, Cristina
The additional diagnostic value of contemporary evaluation of FDG PET/CT scan and contrast enhanced CT imaging both acquired by a last generation PET/CT system in oncologic patients.
2013-01-01 Nanni C; Zompatori M; Ambrosini V; Montesi V; Mezzetti S; Ferretti A; Chondrogiannis S; Rubello D; Fanti S.
Cancer-associated stroma affects FDG uptake in experimental carcinomas. Implications for FDG-PET delineation of radiotherapy target.
2009-01-01 Farace P.; D'Ambrosio D.; Merigo F.; Galiè M.; Nanni C.; Spinelli A.; Fanti S.; Degrassi A.; Sbarbati A.; Rubello D.; Marzola P.
CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance.
2010-01-01 Quarta C.; Bellocchio L.; Mancini G.; Mazza R.; Cervino C.; Braulke L.J.; Fekete C.; Latorre R.; Nanni C.; Bucci M.; Clemens L.E.; Heldmaier G.; Watanabe M.; Leste-Lassere T.; Maitre M.; Tedesco L.; Fanelli F.; Reuss S.; Klaus S.; Srivastava R.K.; Monory K.; Valerio A.; Grandis A.; De Giorgio R.; Pasquali R.; Nisoli E.; Cota D.; Lutz B.; Marsicano G.; Pagotto U.
Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET.
2008-01-01 Tsamita C.S.; Golemi A.; Egesta L.; Castellucci P.; Nanni C.; Stefoni V.; Grassetto G.; Rubello D.; Tani M.; Zinzani P.L.; Fanti S.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| 11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma. | Maleddu A.; Pantaleo M.A.; Castellucci P.; Astorino M.; Nanni C.; Nannini M.; Busato F.; Di Battista M.; Farsad M.; Lodi F.; Boschi S.; Fanti S.; Biasco G. | 2009-01-01 | TUMORI | - | 1.01 Articolo in rivista | - |
| 11C-Choline PET/CT in hormonal resistant patients after radical prostatectomy | Francesco Ceci, Paolo Castellucci, Riccardo Schiavina, Chiara Fuccio, Stefano Boschi, Daniele Romagnoli, Elena Tabacchi, Marcelo Mamede, Cristina Nanni, Stefano Fanti | 2013-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 4.02 Riassunto (Abstract) | - |
| 11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications | Bonfiglioli, Rachele; Nanni, Cristina; Martignani, Cristian; Zanoni, Lucia; La Donna, Raffaele; Diemberger, Igor; Boriani, Giuseppe; Pettinato, Cinzia; Sambuceti, Gianmario; Fanti, Stefano; Mansi, Luigi | 2014-01-01 | CURRENT RADIOPHARMACEUTICALS | - | 1.01 Articolo in rivista | - |
| (18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging. | Lopci E.; Burnelli R.; Ambrosini V.; Nanni C.; Castellucci P.; Biassoni L.; Rubello D.; Fanti S. | 2008-01-01 | CANCER BIOTHERAPY & RADIOPHARMACEUTICALS | - | 1.01 Articolo in rivista | - |
| 18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR. | Lopci E.; Piccardo A.; Nanni C.; Altrinetti V.; Garaventa A.; Pession A.; Cistaro A.; Chiti A.; Villavecchia G.; Fanti S. | 2012-01-01 | CLINICAL NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| 18F-FACBC COMPARED WITH 11C-CHOLINE PET/CT IN PATIENTS WITH BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY: A PROSPECTIVE STUDY IN 79 PATIENTS | R. Schiavina; C. Pultrone; L. Zanoni; C. Nanni; M. Borghesi; V. Vagnoni; G. Passaretti; L. Bianchi; G. Gentile; C. Del Prete; S. Fanti; G. Martorana; E. Brunocilla | 2014-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| 18F-FACBC PET/CT in comparison to 11c-choline for the detection of prostate cancer relapse after radical prostatectomy: A perspective study in 50 patients | R. Schiavina; E. Brunocilla; C. Nanni; M. Borghesi; F. Ceci; L. Zanoni; V. Vagnoni; L. Della Mora; M. Cevenini; C. Del Prete; S. Fanti; G. Martorana | 2014-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone. | Nanni C; Rubello D; Zamagni E; Castellucci P; Ambrosini V; Montini G; Cavo M; Lodi F; Pettinato C; Grassetto G; Franchi R; Gross MD; Fanti S. | 2008-01-01 | IN VIVO | - | 1.01 Articolo in rivista | - |
| 18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin | Ambrosini V; Nanni C; Rubello D; Moretti A; Battista G; Castellucci P; Farsad M; Rampin L; Fiorentini G; Franchi R; Canini R; Fanti S. | 2006-01-01 | LA RADIOLOGIA MEDICA | - | 1.01 Articolo in rivista | - |
| 18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse A Comparison to 11C-Choline PET/CT | Nanni C; Schiavina R; Brunocilla E; Boschi S; Borghesi M; Zanoni L; Pettinato C; Martorana G; Fanti S | 2015-01-01 | CLINICAL NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| (68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. | Ambrosini V.; Nanni C.; Zompatori M.; Campana D.; Tomassetti P.; Castellucci P.; Allegri V.; Rubello D.; Montini G.; Franchi R.; Fanti S. | 2010-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| 68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results. | Nanni C.; Errani C.; Boriani L.; Fantini L.; Ambrosini V.; Boschi S.; Rubello D.; Pettinato C.; Mercuri M.; Gasbarrini A.; Fanti S. | 2010-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| 68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results. | Ambrosini V.; Zompatori M.; De Luca F.; D'Errico A.; Allegri V.; Nanni C.; Malvi D.; Tonveronachi E.; Fasano L.; Fabbri M.; Fanti S. | 2010-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| 68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors. | Ambrosini V.; Campana D.; Bodei L.; Nanni C.; Castellucci P.; Allegri V.; Montini G.C.; Tomassetti P.; Paganelli G.; Fanti S. | 2010-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| A novel model of CCl4-induced cirrosi with ascites in the mouse. | Domenicali M; Caraceni P; Giannone F; Baldassarre M; Lucchetti G; Quarta C; Patti C; Catani L; Nanni C; Lemoli RM; Bernardi M. | 2009-01-01 | JOURNAL OF HEPATOLOGY | - | 1.01 Articolo in rivista | - |
| A review discussing fluciclovine (18F) PET/CT imaging in the detection of recurrent prostate cancer | Zanoni, Lucia; Bossert, Irene; Matti, Antonella; Schiavina, Riccardo; Pultrone, Cristian; Fanti, Stefano; Nanni, Cristina | 2018-01-01 | FUTURE ONCOLOGY | - | 1.01 Articolo in rivista | - |
| The additional diagnostic value of contemporary evaluation of FDG PET/CT scan and contrast enhanced CT imaging both acquired by a last generation PET/CT system in oncologic patients. | Nanni C; Zompatori M; Ambrosini V; Montesi V; Mezzetti S; Ferretti A; Chondrogiannis S; Rubello D; Fanti S. | 2013-01-01 | BIOMÉDECINE & PHARMACOTHÉRAPIE | - | 1.01 Articolo in rivista | - |
| Cancer-associated stroma affects FDG uptake in experimental carcinomas. Implications for FDG-PET delineation of radiotherapy target. | Farace P.; D'Ambrosio D.; Merigo F.; Galiè M.; Nanni C.; Spinelli A.; Fanti S.; Degrassi A.; Sbarbati A.; Rubello D.; Marzola P. | 2009-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. | Quarta C.; Bellocchio L.; Mancini G.; Mazza R.; Cervino C.; Braulke L.J.; Fekete C.; Latorre R.; Nanni C.; Bucci M.; Clemens L.E.; Heldmaier G.; Watanabe M.; Leste-Lassere T.; Maitre M.; Tedesco L.; Fanelli F.; Reuss S.; Klaus S.; Srivastava R.K.; Monory K.; Valerio A.; Grandis A.; De Giorgio R.; Pasquali R.; Nisoli E.; Cota D.; Lutz B.; Marsicano G.; Pagotto U. | 2010-01-01 | CELL METABOLISM | - | 1.01 Articolo in rivista | - |
| Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET. | Tsamita C.S.; Golemi A.; Egesta L.; Castellucci P.; Nanni C.; Stefoni V.; Grassetto G.; Rubello D.; Tani M.; Zinzani P.L.; Fanti S. | 2008-01-01 | NUCLEAR MEDICINE COMMUNICATIONS | - | 1.01 Articolo in rivista | - |